Juan Xu

2.8k total citations
98 papers, 1.9k citations indexed

About

Juan Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Juan Xu has authored 98 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 34 papers in Cancer Research and 23 papers in Oncology. Recurrent topics in Juan Xu's work include Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (11 papers) and Circular RNAs in diseases (9 papers). Juan Xu is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), RNA modifications and cancer (11 papers) and Circular RNAs in diseases (9 papers). Juan Xu collaborates with scholars based in China, United States and Russia. Juan Xu's co-authors include Xuemei Jia, Pengfei Xu, Ziyi Fu, Na Sheng, Chencheng Dai, Xingxu Huang, Teng Fang, Fuzhou Ye, Xinyu Liu and Yi Sun and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Juan Xu

92 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Juan Xu China	24	1.1k	672	382	293	172	98	1.9k
Hongbo Wang China	22	765 0.7×	446 0.7×	301 0.8×	197 0.7×	121 0.7×	99	1.8k
Chaoyang Sun China	27	1.2k 1.2×	536 0.8×	693 1.8×	286 1.0×	145 0.8×	87	2.2k
Yanhong Ni China	28	1.3k 1.3×	801 1.2×	578 1.5×	467 1.6×	240 1.4×	97	2.4k
Ting Hu China	23	757 0.7×	514 0.8×	600 1.6×	379 1.3×	124 0.7×	71	1.7k
Wenjun Cheng China	22	1.2k 1.2×	769 1.1×	376 1.0×	192 0.7×	188 1.1×	76	2.4k
Renquan Lu China	21	625 0.6×	343 0.5×	405 1.1×	121 0.4×	130 0.8×	62	1.2k
Roopali Roy United States	18	798 0.8×	628 0.9×	639 1.7×	128 0.4×	286 1.7×	27	1.9k
Maya Kansara Australia	14	1.3k 1.2×	631 0.9×	574 1.5×	229 0.8×	89 0.5×	31	2.2k
Jinghuan Li China	21	1.4k 1.4×	1.0k 1.5×	199 0.5×	202 0.7×	132 0.8×	51	2.2k
Walburgis Brenner Germany	29	1.2k 1.2×	428 0.6×	615 1.6×	263 0.9×	238 1.4×	112	2.3k

Countries citing papers authored by Juan Xu

Since Specialization

Citations

This map shows the geographic impact of Juan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Xu more than expected).

Fields of papers citing papers by Juan Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Xu. The network helps show where Juan Xu may publish in the future.

Co-authorship network of co-authors of Juan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Xu. A scholar is included among the top collaborators of Juan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Xu. Juan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Li, Xia Yang, Gaohua Han, et al.. (2025). Comparisons of blood, upper respiratory tract and gut viromes from patients with lung cancer and healthy persons. International Journal of Cancer. 157(9). 1924–1938.

Xu, Shengjie, et al.. (2025). Diagnostic Value of ADC in Distinguishing Endometrial Cancer from Atypical Endometrial Hyperplasia and Within Molecular Subtypes. International Journal of Women s Health. Volume 17. 485–495.

Wang, Xinmei, et al.. (2024). Necessity of systematic pelvic lymphadenectomy for early-stage cervical cancer. European Journal of Gynaecological Oncology. 45(2). 44–44. 1 indexed citations

Cui, Xin, Juan Xu, & Xuemei Jia. (2024). Targeting mitochondria: a novel approach for treating platinum-resistant ovarian cancer. Journal of Translational Medicine. 22(1). 968–968. 4 indexed citations

Liu, Xiangyan, Zhen Zhang, Juan Xu, et al.. (2024). Supplementation of Ampelopsis grossedentata extract contributes to the improvement of intestinal health in swine. Frontiers in Veterinary Science. 11. 1417309–1417309. 1 indexed citations

Huang, Chao‐Yuan, Deqiang Wang, Qianqian Wang, et al.. (2023). Lactate induced mesenchymal stem cells activation promotes gastric cancer cells migration and proliferation. Experimental Cell Research. 424(1). 113492–113492. 15 indexed citations

Li, Rong, Juan Xu, Shuna Liu, et al.. (2023). Circulating CD4+ Treg, CD8+ Treg, and CD3+ γδ T Cell Subpopulations in Ovarian Cancer. Medicina. 59(2). 205–205. 5 indexed citations

Sun, Yu, Xiyi Chen, Juan Lv, et al.. (2023). IGF2BP2 promotes ovarian cancer growth and metastasis by upregulating CKAP2L protein expression in an m ⁶ A ‐dependent manner. The FASEB Journal. 37(10). e23183–e23183. 12 indexed citations

Liu, Shuna, Ziqi Tao, Jianfang Lou, et al.. (2023). CD4+CCR8+ Tregs in ovarian cancer: a potential effector Tregs for immune regulation. Journal of Translational Medicine. 21(1). 803–803. 11 indexed citations

10.

Zhou, Zihan, Peifeng Li, Xianbin Zhang, et al.. (2022). Mutational landscape of nasopharyngeal carcinoma based on targeted next-generation sequencing: implications for predicting clinical outcomes. Molecular Medicine. 28(1). 55–55. 7 indexed citations

11.

Li, Jingyun, et al.. (2022). Peptide PDHPS1 Inhibits Ovarian Cancer Growth through Disrupting YAP Signaling. Molecular Cancer Therapeutics. 21(7). 1160–1170. 4 indexed citations

12.

Ge, Lili, Yu Sun, Teng Fang, et al.. (2022). Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer. Journal of Ovarian Research. 15(1). 58–58. 28 indexed citations

13.

Xu, Juan, et al.. (2022). Construction of Novel Prognostic Nomogram for Mucinous and Signet Ring Cell Colorectal Cancer Patients with a Survival Longer Than 5 Years. SHILAP Revista de lepidopterología. 3 indexed citations

14.

Luo, Bo, Xinhong Wu, Hongmei Zheng, et al.. (2021). Nuclear Her2 contributes to paclitaxel resistance in breast cancer cells. Anti-Cancer Drugs. 32(7). 709–716. 6 indexed citations

15.

Liu, Siyu, Min Zhang, Guangquan Liu, et al.. (2019). LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells. Cancer Biotherapy and Radiopharmaceuticals. 34(5). 316–324. 17 indexed citations

16.

Xu, Luang, Xinyu Liu, Na Sheng, et al.. (2017). Three distinct 3-methylcytidine (m3C) methyltransferases modify tRNA and mRNA in mice and humans. Journal of Biological Chemistry. 292(35). 14695–14703. 164 indexed citations

17.

Xu, Juan, Teng Fang, Siyu Liu, et al.. (2017). Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells. Journal of Cellular Physiology. 233(6). 5034–5043. 30 indexed citations

18.

Luo, Bo, et al.. (2013). Efficiency and prognosis of whole brain irradiation combined with precise radiotherapy on triple-negative breast cancer. Journal of Cancer Research and Therapeutics. 9(7). 169–169. 4 indexed citations

19.

Xu, Juan, Meizhi Wang, Xinxing Gao, et al.. (2011). Separase Phosphosite Mutation Leads to Genome Instability and Primordial Germ Cell Depletion during Oogenesis. PLoS ONE. 6(4). e18763–e18763. 10 indexed citations

20.

Gu, Yongquan, Jiän Zhang, Lianrui Guo, et al.. (2008). Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia. Chinese Medical Journal. 121(11). 963–967. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact